ReviewExpert opinion on biological therapy2012

Benralizumab--a humanized mAb to IL-5Rα with enhanced antibody-dependent cell-mediated cytotoxicity--a novel approach for the treatment of asthma.

Aasia Ghazi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.